Form D · Other Health Care
NeuroSigma, Inc.
Los Angeles, CA · CIK 0001494756
Offering snapshot reported Aug 31, 2016 · SEC filing
- Reported sold
- $11.7M Indefinite offering
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 25, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 31, 2016 | Initial | $11,653,514 | No comparison | 9 | SEC filing |
| Mar 10, 2011 | Amendment | $1,210,000 | $760,000vs Jun 23, 2010 | 11 | SEC filing |
| Feb 14, 2011 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Jun 23, 2010 | Initial | $450,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-269840
Existing purchase agreements and the applicable existing notes are being exchanged for convertible promissory notes.
Source: Form D, filed Aug 31, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kirk Calhoun | Director |
| Lodwrick M. Cook | Director |
| Leon Ekchian | Director, Executive |
| James Hindman | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
10960 Wilshire Blvd. Suite 1910
Los Angeles, CA, 90024
Los Angeles, CA, 90024